XML 18 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Income/(Loss) and Comprehensive Income/(Loss) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Apr. 30, 2020
Income Statement [Abstract]      
Net sales $ 864,126 $ 1,059,195 $ 529,618
Cost of sales 489,562 610,212 363,929
Gross profit 374,564 448,983 165,689
Operating expenses:      
Research and development 7,262 7,480 7,364
Selling, marketing, and distribution 43,156 42,603 41,987
General and administrative 72,493 79,268 66,033
Total operating expenses 122,911 129,351 115,384
Operating income from continuing operations 251,653 319,632 50,305
Other income/(expense), net:      
Other income/(expense), net 2,868 2,252 495
Interest expense, net (2,135) (3,919) (11,625)
Total other income/(expense), net 733 (1,667) (11,130)
Income from continuing operations before income taxes 252,386 317,965 39,175
Income tax expense 57,892 74,394 11,522
Income from continuing operations 194,494 243,571 27,653
Discontinued operations:      
Income/(loss) from discontinued operations, net of tax 0 8,478 (88,883)
Net income/(loss) 194,494 252,049 (61,230)
Comprehensive income/(loss):      
Other comprehensive loss, net of tax 0 0 (547)
Comprehensive income/(loss): $ 194,494 $ 252,049 $ (61,777)
Net income/(loss) per share:      
Basic - continuing operations $ 4.12 $ 4.46 $ 0.50
Basic - Net income/(loss) 4.12 4.62 (1.11)
Diluted - continuing operations 4.08 4.40 0.50
Diluted - Net income/(loss) $ 4.08 $ 4.55 $ (1.10)
Weighted average number of common shares outstanding:      
Basic 47,227 54,613 54,983
Diluted 47,728 55,352 55,665